Opening the field of integrin biology to "biased agonism".
作者信息
Simon Daniel I
出版信息
Circ Res. 2011 Nov 11;109(11):1199-201. doi: 10.1161/CIRCRESAHA.111.257980.
Abstract
摘要
相似文献
1
Opening the field of integrin biology to "biased agonism".
Circ Res. 2011 Nov 11;109(11):1199-201. doi: 10.1161/CIRCRESAHA.111.257980.
2
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.
Circ Res. 2011 Nov 11;109(11):1269-79. doi: 10.1161/CIRCRESAHA.111.247684. Epub 2011 Oct 13.
3
CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
Circulation. 2007 Mar 27;115(12):1571-80. doi: 10.1161/CIRCULATIONAHA.106.683201. Epub 2007 Mar 19.
4
CD154 and its receptors in inflammatory vascular pathologies.
Trends Immunol. 2009 Apr;30(4):165-72. doi: 10.1016/j.it.2009.01.004. Epub 2009 Mar 11.
5
Fundamentally different roles for LFA-1, Mac-1 and alpha4-integrin in neutrophil chemotaxis.
J Cell Sci. 2005 Nov 15;118(Pt 22):5205-20. doi: 10.1242/jcs.02632. Epub 2005 Oct 25.
6
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Nat Commun. 2018 Feb 6;9(1):525. doi: 10.1038/s41467-018-02896-8.
7
Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice.
Thromb Haemost. 2014 Aug;112(2):379-89. doi: 10.1160/TH13-08-0653. Epub 2014 Mar 20.
8
[Increase of the membrane-bound urokinase level in monocytes from patients with atherosclerosis is accompanied by decrease of urokinase-induced myocyte migration].
Biull Eksp Biol Med. 1998 Aug;126(8):147-9.
9
CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.
Am J Pathol. 2008 Apr;172(4):1141-52. doi: 10.2353/ajpath.2008.070633. Epub 2008 Mar 18.
10
CD40 ligand expression correlates with resolution of peritonitis and mononuclear cell recruitment.
Perit Dial Int. 2005 May-Jun;25(3):240-7.
引用本文的文献
1
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands.
J Med Chem. 2025 Feb 27;68(4):4334-4351. doi: 10.1021/acs.jmedchem.4c02111. Epub 2025 Feb 5.
2
Integrins in Health and Disease-Suitable Targets for Treatment?
Cells. 2024 Jan 23;13(3):212. doi: 10.3390/cells13030212.
3
Evidence for functional selectivity in TUDC- and norUDCA-induced signal transduction via αβ integrin towards choleresis.
Sci Rep. 2020 Apr 2;10(1):5795. doi: 10.1038/s41598-020-62326-y.
4
Different Calcium and Src Family Kinase Signaling in Mac-1 Dependent Phagocytosis and Extracellular Vesicle Generation.
Front Immunol. 2019 Dec 17;10:2942. doi: 10.3389/fimmu.2019.02942. eCollection 2019.
5
Role of Mac-1 integrin in generation of extracellular vesicles with antibacterial capacity from neutrophilic granulocytes.
J Extracell Vesicles. 2019 Dec 9;9(1):1698889. doi: 10.1080/20013078.2019.1698889. eCollection 2020.
6
Leukocyte integrin signaling regulates FOXP1 gene expression via FOXP1-IT1 long non-coding RNA-mediated IRAK1 pathway.
Biochim Biophys Acta Gene Regul Mech. 2019 Apr;1862(4):493-508. doi: 10.1016/j.bbagrm.2019.02.008. Epub 2019 Mar 2.
7
Structural Immunology of Complement Receptors 3 and 4.
Front Immunol. 2018 Nov 26;9:2716. doi: 10.3389/fimmu.2018.02716. eCollection 2018.
8
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Nat Commun. 2018 Feb 6;9(1):525. doi: 10.1038/s41467-018-02896-8.
9
Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators.
Cancers (Basel). 2017 Jul 5;9(7):78. doi: 10.3390/cancers9070078.
10
CD40L and Its Receptors in Atherothrombosis-An Update.
Front Cardiovasc Med. 2017 Jun 20;4:40. doi: 10.3389/fcvm.2017.00040. eCollection 2017.
本文引用的文献
1
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.
Circ Res. 2011 Nov 11;109(11):1269-79. doi: 10.1161/CIRCRESAHA.111.247684. Epub 2011 Oct 13.
2
Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury.
Circulation. 2009 Sep 29;120(13):1255-65. doi: 10.1161/CIRCULATIONAHA.109.873695. Epub 2009 Sep 14.
3
Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function.
Blood. 2008 Dec 1;112(12):4699-711. doi: 10.1182/blood-2008-01-137018. Epub 2008 Sep 17.
4
Beta-arrestin-biased ligands at seven-transmembrane receptors.
Trends Pharmacol Sci. 2007 Aug;28(8):416-22. doi: 10.1016/j.tips.2007.06.006. Epub 2007 Jul 20.
5
A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18.
J Biomol Screen. 2007 Apr;12(3):406-17. doi: 10.1177/1087057106299162.
6
Mac-1 signaling via Src-family and Syk kinases results in elastase-dependent thrombohemorrhagic vasculopathy.
Immunity. 2006 Aug;25(2):271-83. doi: 10.1016/j.immuni.2006.05.014. Epub 2006 Jul 27.
7
Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1.
J Clin Invest. 2004 Aug;114(3):408-18. doi: 10.1172/JCI21100.
8
Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha.
J Exp Med. 2003 Oct 6;198(7):1077-88. doi: 10.1084/jem.20022181.
9
Delineation of the key amino acids involved in neutrophil inhibitory factor binding to the I-domain supports a mosaic model for the capacity of integrin alphaMbeta 2 to recognize multiple ligands.
J Biol Chem. 2002 May 24;277(21):18769-76. doi: 10.1074/jbc.M110242200. Epub 2002 Mar 5.
10
Leukocyte integrin Mac-1 recruits toll/interleukin-1 receptor superfamily signaling intermediates to modulate NF-kappaB activity.
Circ Res. 2001 Nov 9;89(10):859-65. doi: 10.1161/hh2201.099166.
Zotero 插件